79 related articles for article (PubMed ID: 3736185)
1. [Generation of eosinophil chemotactic factor of anaphylaxis in patients with cold urticaria and study of its in vitro chemotactic deactivation].
Ibáñez MD; Leyva Cobián F; Díaz Gómez ML
Med Clin (Barc); 1986 May; 86(19):794-7. PubMed ID: 3736185
[No Abstract] [Full Text] [Related]
2. Cold urticaria: release into the circulation of histamine and eosinophil chemotactic factor of anaphylaxis during cold challenge.
Soter NA; Wasserman SI; Austen KF
N Engl J Med; 1976 Mar; 294(13):687-90. PubMed ID: 55969
[TBL] [Abstract][Full Text] [Related]
3. Presence of factors chemotactic for granulocytes in hypereosinophilic syndrome sera: relation with alterations in eosinophil migration.
Gosset P; Prin L; Capron M; Auriault C; Tonnel AB; Capron A
Clin Exp Immunol; 1986 Sep; 65(3):654-63. PubMed ID: 3780047
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of neutrophil chemotaxis in association with experimental angioedema in patients with cold urticaria: a model of chemotactic deactivation in vivo.
Center DM; Soter NA; Wasserman SI; Austen KF
Clin Exp Immunol; 1979 Jan; 35(1):112-8. PubMed ID: 428142
[TBL] [Abstract][Full Text] [Related]
5. Release of mast-cell mediators and alterations in lung function in patients with cholinergic urticaria.
Soter NA; Wasserman SI; Austen KF; McFadden ER
N Engl J Med; 1980 Mar; 302(11):604-8. PubMed ID: 7351907
[TBL] [Abstract][Full Text] [Related]
6. [Granulocytic "deactivation" in cold urticaria].
Del Sere F; Gerini G; Velluzzi M; Petrini N; Fabbri P
G Ital Dermatol Venereol; 1990 Oct; 125(10):423-8. PubMed ID: 2081620
[TBL] [Abstract][Full Text] [Related]
7. Serum levels of neutrophil and eosinophil chemotactic activities in mastocytosis.
Granerus G; Håkansson L; Roupe G; Venge P
Agents Actions; 1989 Apr; 27(1-2):208-11. PubMed ID: 2473624
[TBL] [Abstract][Full Text] [Related]
8. Neutrophil and eosinophil chemotaxins in asthma.
Teran LM; Montefort S; Douglass J; Holgate ST
Q J Med; 1993 Dec; 86(12):761-9. PubMed ID: 8108534
[No Abstract] [Full Text] [Related]
9. The release of eosinophil chemotactic activity and eosinophil chemokinesis inhibitory activity by mononuclear cells from atopic asthmatic and non-atopic subjects.
Grzegorczyk J; Majkowska-Wojciechowska B; Kowalski ML
Mediators Inflamm; 2000; 9(1):7-13. PubMed ID: 10877449
[TBL] [Abstract][Full Text] [Related]
10. The functional and physicochemical characterization of three eosinophilotactic activities released into the circulation by cold challenge of patients with cold urticaria.
Wasserman SI; Austen KF; Soter NA
Clin Exp Immunol; 1982 Mar; 47(3):570-8. PubMed ID: 7083632
[TBL] [Abstract][Full Text] [Related]
11. Release of eosinophil chemotactic leukotriene from neutrophils of patients with pseudo-allergic reactions.
Czarnetzki BM
Int Arch Allergy Appl Immunol; 1983; 70(1):78-82. PubMed ID: 6293981
[TBL] [Abstract][Full Text] [Related]
12. Chemotactic deactivation of human eosinophils by the eosinophil chemotactic factor of anaphylaxis (38527).
Wasserman SI; Whitmer D; Geotzl EJ; Austen KF
Proc Soc Exp Biol Med; 1975 Jan; 148(1):301-6. PubMed ID: 1129271
[TBL] [Abstract][Full Text] [Related]
13. Eosinophil and neutrophil chemotactic activities of adult worm extracts of Schistosoma japonicum in vivo and in vitro.
Horii Y; Owhashi M; Ishii A; Bandou K; Usui M
J Parasitol; 1984 Dec; 70(6):955-61. PubMed ID: 6098637
[TBL] [Abstract][Full Text] [Related]
14. The effects of a soluble factor released by sensitized mononuclear cells incubated with S. haematobium ova on eosinophil migration.
Wadee AA; Sher R
Immunology; 1980 Dec; 41(4):989-95. PubMed ID: 7461720
[TBL] [Abstract][Full Text] [Related]
15. Low molecular weight eosinophil chemotactic factor (ECF) in the serum of murine schistosomiasis japonica.
Owhashi M; Horii Y; Ishii A; Nawa Y
Int Arch Allergy Appl Immunol; 1986; 79(2):178-81. PubMed ID: 3080375
[TBL] [Abstract][Full Text] [Related]
16. Generation of leukotrienes and lipoxygenase factors from human polymorphonuclear granulocytes during bacterial phagocytosis and interaction with bacterial exotoxins.
Bremm KD; Brom J; König W; Spur B; Crea A; Bhakdi S; Lutz F; Fehrenbach FJ
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Jul; 254(4):500-14. PubMed ID: 6326424
[TBL] [Abstract][Full Text] [Related]
17. The mediation of tissue eosinophilia in hypersensitivity reactions. IV. Production of delayed eosinophil chemotactic factor-a by peritoneal exudate cells from sensitized guinea-pigs in vitro.
Hirashima M; Hirotsu Y; Hayashi H
Immunology; 1983 Jan; 48(1):69-77. PubMed ID: 6848455
[TBL] [Abstract][Full Text] [Related]
18. The effects of an ECF-A and formyl methionyl chemotactic peptides on oxidative metabolism of human eosinophils and neutrophils.
Beswick PH; Kay AB
Clin Exp Immunol; 1981 Feb; 43(2):399-407. PubMed ID: 6268337
[TBL] [Abstract][Full Text] [Related]
19. Leukotriene B4 and neutrophil-derived eosinophil chemotactic factor: comparison of their biological activities.
Czarnetzki BM; Frosch PJ; Mardin M; Macher E
Monogr Allergy; 1983; 18():193-5. PubMed ID: 6316127
[No Abstract] [Full Text] [Related]
20. Induction and comparison of the eosinophil chemotactic factor with endogenous hydroxyeicosatetraenoic acids: its inhibition by arachidonic acid analogs.
König W; Kunau HW; Borgeat P
Adv Prostaglandin Thromboxane Leukot Res; 1982; 9():301-14. PubMed ID: 6211958
[No Abstract] [Full Text] [Related]
[Next] [New Search]
